STAA Staar Surgical Co

Price (delayed)

$89.37

Market cap

$4.25B

P/E Ratio

182.39

Dividend/share

N/A

EPS

$0.49

Enterprise value

$4.08B

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are ...

Highlights
Staar Surgical's net income has soared by 156% YoY and by 10% from the previous quarter
Staar Surgical's EPS has surged by 145% YoY and by 11% QoQ
Staar Surgical's debt has soared by 143% YoY and by 83% from the previous quarter
STAA's quick ratio is down by 4% QoQ

Key stats

What are the main financial stats of STAA
Market
Shares outstanding
47.6M
Market cap
$4.25B
Enterprise value
$4.08B
Valuations
Price to earnings (P/E)
182.39
Price to book (P/B)
17
Price to sales (P/S)
19.51
EV/EBIT
139.96
EV/EBITDA
125
EV/Sales
18.77
Earnings
Revenue
$217.47M
EBIT
$29.16M
EBITDA
$32.65M
Free cash flow
$43.91M
Per share
EPS
$0.49
Free cash flow per share
$0.92
Book value per share
$5.26
Revenue per share
$4.58
TBVPS
$6.79
Balance sheet
Total assets
$324.61M
Total liabilities
$75.5M
Debt
$23.44M
Equity
$249.11M
Working capital
$217.15M
Liquidity
Debt to equity
0.09
Current ratio
5.64
Quick ratio
5.09
Net debt/EBITDA
-5.29
Margins
EBITDA margin
15%
Gross margin
77.2%
Net margin
10.5%
Operating margin
13.8%
Efficiency
Return on assets
8%
Return on equity
10.2%
Return on invested capital
34.2%
Return on capital employed
10.5%
Return on sales
13.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

STAA stock price

How has the Staar Surgical stock price performed over time
Intraday
-2.95%
1 week
-8.04%
1 month
-25.75%
1 year
19.02%
YTD
12.81%
QTD
-30.47%

Financial performance

How have Staar Surgical's revenue and profit performed over time
Revenue
$217.47M
Gross profit
$167.95M
Operating income
$29.95M
Net income
$22.91M
Gross margin
77.2%
Net margin
10.5%
Staar Surgical's net income has soared by 156% YoY and by 10% from the previous quarter
Staar Surgical's net margin has soared by 84% YoY and by 4% from the previous quarter
The gross profit has grown by 49% year-on-year and by 7% since the previous quarter
The revenue has grown by 39% YoY and by 5% from the previous quarter

Growth

What is Staar Surgical's growth rate over time

Valuation

What is Staar Surgical stock price valuation
P/E
182.39
P/B
17
P/S
19.51
EV/EBIT
139.96
EV/EBITDA
125
EV/Sales
18.77
Staar Surgical's EPS has surged by 145% YoY and by 11% QoQ
STAA's P/E is 56% below its last 4 quarters average of 414.7
Staar Surgical's equity has increased by 34% YoY and by 6% QoQ
STAA's price to book (P/B) is 28% lower than its last 4 quarters average of 23.7 but 15% higher than its 5-year quarterly average of 14.8
The stock's price to sales (P/S) is 46% more than its 5-year quarterly average of 13.4 but 30% less than its last 4 quarters average of 27.7
The revenue has grown by 39% YoY and by 5% from the previous quarter

Efficiency

How efficient is Staar Surgical business performance
The ROE has soared by 96% YoY and by 2% from the previous quarter
Staar Surgical's return on assets has surged by 95% YoY

Dividends

What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for STAA.

Financial health

How did Staar Surgical financials performed over time
Staar Surgical's total liabilities has soared by 56% YoY and by 26% from the previous quarter
The total assets is up by 38% year-on-year and by 10% since the previous quarter
Staar Surgical's debt is 91% less than its equity
Staar Surgical's debt has soared by 143% YoY and by 83% from the previous quarter
The company's debt to equity has surged by 80% QoQ and by 80% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.